Literature DB >> 8682837

The outcome and functional results of diaphyseal endoprostheses after tumour excision.

A Abudu1, S R Carter, R J Grimer.   

Abstract

Improvement in the life expectancy of patients with primary bone tumours has led to increased emphasis on limb salvage and preservation of function. Between 1979 and 1994 we used custom-made endoprostheses in 18 patients to reconstruct diaphyseal defects after excision of primary bone tumours. The mean age at operation was 26 years (9 to 64) and the median follow-up 65 months (6 to 188). Fifteen patients have survived and are free from local or metastatic disease. Local recurrence developed in one patient. Using the modified Enneking functional scoring system, 77% of the patients achieved 80% or more of their premorbid functional capability. Mechanical loosening, limb shortening and secondary osteoarthritis were the main complications. There were no infections. We conclude that diaphyseal endoprostheses offer a good clinical and functional outcome in the lower limb.

Entities:  

Mesh:

Year:  1996        PMID: 8682837

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  29 in total

1.  Custom megaprosthetic replacement for proximal tibial tumours.

Authors:  Mayil Vahanan Natarajan; A Sivaseelam; G Rajkumar; S H Jaheer Hussain
Journal:  Int Orthop       Date:  2003-06-28       Impact factor: 3.075

2.  CORR Insights(®): Outcomes of a Modular Intercalary Endoprosthesis as Treatment for Segmental Defects of the Femur, Tibia, and Humerus.

Authors:  Reinhard Windhager
Journal:  Clin Orthop Relat Res       Date:  2015-11-19       Impact factor: 4.176

3.  Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.

Authors:  Krista A Goulding; Adam Schwartz; Steven J Hattrup; R Lor Randall; Donald Lee; Damian M Rispoli; Daniel M Lerman; Christopher Beauchamp
Journal:  Clin Orthop Relat Res       Date:  2017-02-13       Impact factor: 4.176

Review 4.  Intercalary reconstructions after bone tumor resections: a review of treatments.

Authors:  Georgios N Panagopoulos; Andreas F Mavrogenis; Cyril Mauffrey; Jan Lesenský; Andrea Angelini; Panayiotis D Megaloikonomos; Vasilios G Igoumenou; John Papanastassiou; Olga Savvidou; Pietro Ruggieri; Panayiotis J Papagelopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-05

5.  Is the Induced-membrane Technique Successful for Limb Reconstruction After Resecting Large Bone Tumors in Children?

Authors:  Frank Fitoussi; Brice Ilharreborde
Journal:  Clin Orthop Relat Res       Date:  2015-01-30       Impact factor: 4.176

6.  Outcomes of a Modular Intercalary Endoprosthesis as Treatment for Segmental Defects of the Femur, Tibia, and Humerus.

Authors:  Joseph Benevenia; Rainer Kirchner; Francis Patterson; Kathleen Beebe; Dieter C Wirtz; Steven Rivero; Mark Palma; Max J Friedrich
Journal:  Clin Orthop Relat Res       Date:  2016-02       Impact factor: 4.176

7.  Failure rates and functional results for intercalary femur reconstructions after tumour resection.

Authors:  J I Albergo; L C Gaston; G L Farfalli; M Laitinen; M Parry; M A Ayerza; M Risk; L M Jeys; L A Aponte-Tinao
Journal:  Musculoskelet Surg       Date:  2019-03-08

8.  Distal femoral tumours treated by resection and custom mega-prosthetic replacement.

Authors:  Mayil Vahanan Natarajan; A Sivaseelam; S Ayyappan; Jagadesh Chandra Bose; M Sampath Kumar
Journal:  Int Orthop       Date:  2005-08-31       Impact factor: 3.075

9.  Custom-made intercalary endoprosthetic reconstruction for a parosteal osteosarcoma of the femoral diaphysis: A case report.

Authors:  Shi-Chang Zhao; Chang-Qing Zhang; Chun-Lin Zhang
Journal:  Oncol Lett       Date:  2015-08-24       Impact factor: 2.967

10.  The clinical outcomes of extracorporeal irradiated and re-implanted cemented autologous bone graft of femoral diaphysis after tumour resection.

Authors:  Tomoki Nakamura; Adesegun Abudu; Roger J Grimer; Simon R Carter; Lee Jeys; Roger M Tillman
Journal:  Int Orthop       Date:  2012-12-28       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.